News
This week on “Uncanny Valley,” we talk about one of the most notorious American corporations. So what does Palantir actually ...
Warren Buffett, Michael Burry and Andrew Left may not always agree on which stocks have good valuations. The three are all ...
While the operational momentum is clearly solid, investors should pay closer attention to the risks. History shows Palantir ...
Palantir is riding twin engines of growth with its commercial and government contracts. Will it be enough to sustain its valuation?
Palantir just delivered another mind-blowing quarter. 2024 was an excellent year for Palantir, as the tech company delivered ...
The professional journey of Michael Ash, MD, has taken him from EHR vendor Cerner to a health system IT executive to, now, the CEO of Omaha-based Nebraska Medicine. It’s a unique career path that has ...
Palantir Is Now the 19th Largest Public Company. Is This House of Cards About to Come Crashing Down?
As of this writing on Aug. 10, Palantir has ascended the ladder to become the 19th largest publicly traded company in the U.S ...
Palantir Technologies Inc. has fortified its relationship with SOMPO Holdings through a strategic multi-year deal. This ...
A recent partner of Israel, Palantir, has become a global player by using data analysis as a weapon of influence and decision ...
Palantir Technologies Inc. just shattered its previous stock price record, soaring to $18.02. Investors cheered as the tech ...
StockStory.org on MSN2d
PLTR Q2 Deep Dive: U.S. Commercial and AI Demand Accelerate Revenue Growth
Data-mining and analytics company Palantir (NYSE:PLTR) reported Q2 CY2025 results , with sales up 48% year on year to $1.00 ...
Vendor sprawl isn’t a new problem. But for today’s healthcare CIO, it’s become a central concern—one with broad implications for performance, security, and long-term strategy. As CIOs take on expanded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results